Stay updated on Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor system update and does not affect study content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedA consolidated Locations section now lists Ontario and Quebec as study sites, replacing the previous separate location headings; the page revision shows Revision: v3.3.3.SummaryDifference0.4%

- Check53 days agoChange DetectedThe page revision was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the government funding lapse notice and related operating-status information from the page.SummaryDifference0.4%

- Check74 days agoChange DetectedThe changes are minor UI adjustments with no impact on study data or key content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check103 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%

Stay in the know with updates to Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.